![]() |
市場調查報告書
商品編碼
1576937
顱內壓監測設備:市場洞察·競爭環境·市場預測 (~2030年)Intracranial Pressure Monitoring Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
顱內壓監測設備市場規模預計將從 2023 年的 15.5 億美元增至 2030 年的 24 億美元,在 2024-2030 年預測期內複合年增長率為 7.60%。
由於多發性硬化症、癲癇和癡呆症等神經系統疾病病例的增加、對這些疾病的認識的提高以及產品開發活動的增加等因素,顱內壓監測設備的市場正在顯著增長。
顱內壓監測設備市場動態:
根據世界衛生組織 (WHO) 2023 年的數據,據報導全球有超過 180 萬人受到多發性硬化症 (MS) 的影響。多發性硬化症影響多種功能,包括認知、情緒、運動、感覺和視覺功能。當免疫系統錯誤地攻擊大腦和脊髓時就會發生這種情況。
根據世界衛生組織的數據,到2024年,全球將有約5,000萬人受到癲癇的影響,使其成為全球最常見的神經系統疾病之一。近 80% 的癲癇患者生活在低收入和中等收入國家。據估計,如果診斷和治療得當,70% 的癲癇患者可以無癲癇發作。
相同數據顯示,全球有超過 5,500 萬人患有失智症,其中 60% 以上生活在低收入和中等收入國家。每年發生近1000萬例新病例。
由於多發性硬化症、癲癇和癡呆等神經系統疾病的增加,對顱內壓監測設備的需求不斷增加。這些情況通常會引起併發症,需要評估顱內壓以進行有效管理。顱內壓監測裝置對於管理多發性硬化症、癲癇發作期間的繼發效應以及評估癡呆患者的顱內動態至關重要。
本報告提供全球顱內壓監測設備的市場調查,提供市場概要,市場影響因素及市場機會分析,法律制度,市場規模的轉變·預測,各種區分·地區/各主要國家的詳細分析,競爭情形,主要企業簡介等資訊。
Intracranial Pressure Monitoring Devices Market by Technique (Invasive [External Ventricular Drainage (EVD) and Microtransducer ICP Monitoring], and Noninvasive [Transcranial Doppler Ultrasonography, MRI/CT, and Others]), Product Type (Monitors, Probes, Catheters and Kits, and Others), Application (Traumatic Brain Injury, Intracerebral Hemorrhage, Meningitis, and Others), End-User (Hospitals, Homecare, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the increasing instances of neurological disorders and the rising product developmental activities across the globe
The intracranial pressure monitoring devices market was valued at USD 1.55 billion in 2023, growing at a CAGR of 7.60% during the forecast period from 2024 to 2030 to reach USD 2.40 billion by 2030. The intracranial pressure monitoring devices market is experiencing significant growth due to the increasing instances of neurological disorders such as multiple sclerosis and epilepsy, and dementia, coupled with increasing awareness of these disorders, and rising product developmental activities that are acting as major factors contributing to the overall growth of the intracranial pressure monitoring devices market during the forecast period from 2024 to 2030.
Intracranial Pressure Monitoring Devices Market Dynamics:
As per data from the World Health Organization (WHO) (2023), it was reported that over 1.8 million people worldwide are affected by Multiple sclerosis (MS). It impacts various functions including cognitive, emotional, motor, sensory, and visual abilities. It occurs when the immune system mistakenly attacks the brain and spinal cord.
Data from the WHO stated that in 2024, around 50 million people worldwide had epilepsy, making it one of the most common neurological diseases globally. Nearly 80% of people with epilepsy live in low- and middle-income countries. It is estimated that up to 70% of people living with epilepsy could have lived seizure-free if they had been properly diagnosed and treated. Additionally, globally, an estimated 5 million people are diagnosed with epilepsy each year. In high-income countries, there were estimated to be 49 per 100,000 people diagnosed with epilepsy each year, whereas in low- and middle-income countries, this figure could be as high as 139 per 100,000.
According to data from the WHO (2023), it stated that more than 55 million people had dementia worldwide, with over 60% living in low- and middle-income countries. Each year, there were nearly 10 million new cases.
Since neurological disorders such as multiple sclerosis, epilepsy, and dementia are growing, there is increasing demand for intracranial pressure monitoring devices. These conditions often lead to complications requiring intracranial pressure assessment for effective management. For instance, intracranial pressure monitoring devices is critical in managing secondary effects in multiple sclerosis, during seizures in epilepsy, and in dementia patients to evaluate intracranial dynamics.
Hence, the interplay of all the above-mentioned factors is expected to drive the intracranial pressure monitoring devices market during the given forecast period from 2024 to 2030.
However, the dearth of skilled specialists for equipment operation and handling, potential risks associated with intracranial pressure monitoring devices, and others may restrict the market growth for the intracranial pressure monitoring devices market.
Intracranial Pressure Monitoring Devices Market Segment Analysis:
Intracranial Pressure Monitoring Devices Market by Technique (Invasive [External Ventricular Drainage (EVD) and Microtransducer ICP Monitoring], and Noninvasive [Transcranial Doppler Ultrasonography, MRI/CT, and Others]), Product Type (Monitors, Probes, Catheters and Kits, and Others), Application (Traumatic Brain Injury, Intracerebral Hemorrhage, Meningitis, and Others), End-User (Hospitals, Homecare, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the technique segment of the intracranial pressure monitoring devices market, the external ventricular drainage (EVD) sub-category of invasive intracranial pressure monitoring devices is expected to have a significant revenue share in the year 2023. This is due to the numerous advantages and applications in intracranial pressure monitoring offered by external ventricular drainage devices.
External ventricular drainage devices offer numerous advantages in managing patients with critical neurological conditions. These devices provide real-time monitoring and therapeutic relief of elevated intracranial pressure by draining cerebrospinal fluid from the ventricles. EVDs also allow precise control over fluid drainage, ensuring that the brain's pressure remains within safe limits, which helps in preventing secondary brain damage.
Additionally, these devices serve as a diagnostic tool by allowing for cerebrospinal sampling, which is essential in identifying infections like meningitis or monitoring for hemorrhagic complications. EVDs are minimally invasive and can be placed in emergency situations, providing immediate therapeutic effects. Their adjustability and precision make them a vital part of neurocritical care, improving both patient outcomes and survival rates when used timely and under appropriate clinical contexts.
Therefore, the widespread uses and various advantages of external ventricular drainage device enhance performance and usability, solidifying a significant impact on the growth of the overall intracranial pressure monitoring devices market during the forecast period from 2024 to 2030.
North America is expected to dominate the overall intracranial pressure monitoring devices market:
Among all the regions, North America is estimated to hold a significant revenue share in the intracranial pressure monitoring devices market. This can be attributed to several factors, including the growing burden of Parkinson's disease, the increasing prevalence of brain injuries caused by trauma, and ongoing product development activities by regulatory authorities supported by the presence of key players in the region that contribute to the growth of the intracranial pressure monitoring devices market in the North America region during the forecast period from 2024 to 2030.
Parkinson's Foundation in 2024 stated that, currently near about one million people in the U.S. are living with Parkinson's disease. This number is projected to increase to 1.2 million by 2030. Parkinson's disease is the second-most common neurodegenerative disorder, following Alzheimer's disease. Each year, approximately 90,000 new cases of Parkinson's are diagnosed in the US. The increasing prevalence of Parkinson's disease is significantly enhancing the market for intracranial pressure monitoring devices. As the number of diagnosed patients rises, there is a growing need for effective management of neurological complications, including those related to elevated intracranial pressure.
According to data provided by the Centre for Disease Control and Prevention (2024), in 2021, there were more than 586 traumatic brain injury-related hospitalizations per day in the US. Traumatic brain injuries, caused by head trauma from accidents, falls, or sports injuries, require prompt and accurate diagnosis to assess the extent of brain damage and guide treatment decisions. The increasing incidence of traumatic brain injuries is driving demand for intracranial pressure monitoring devices, as traumatic brain injuries result in significant hospitalizations, the need for precise and timely intracranial pressure assessment becomes critical for effective management and prevention of secondary brain injury.
Various product developmental strategies such as clearances in the region by regulatory authorities in the region play a major role in pushing forward the revenue shares of intracranial pressure monitoring devices in the region. For example, in August 2024, Aesculap, Inc., in partnership with Christoph Miethke GmbH & Co. KG, announced the U.S. Food and Drug Administration (FDA) approval for Breakthrough Device Designation for the M.scio(R) System. This unique, non-invasive, telemetric pressure measurement system is designed to provide continuous access to long-term, intracranial pressure monitoring of cerebrospinal fluid for the management of hydrocephalus via a permanent, fully implantable sensor.
Moreover, product launches by key market players in the region is further expected to propel the growth of the North America intracranial pressure monitoring devices market.
Therefore, the interplay of all the factors mentioned above would provide a conducive growth environment for the North America region in the intracranial pressure monitoring devices market during the forecast period from 2024 to 2030.
Intracranial Pressure Monitoring Devices Market key players:
Some of the key market players operating in the intracranial pressure monitoring devices market include ArchiMed Group, RAUMEDIC AG, Integra LifeSciences, Sophysa, Spiegelberg GmbH & Co. KG, Medtronic, IRRAS AB, Luciole Medical AG, Saeum Meditec, Recorders & Medicare Systems P Ltd., Shenzhen Delica Medical Equipment Co., Ltd., Viasonix, ELCAT, Atys Medical, RIMED, GE HealthCare., Siemens Healthcare GmbH, Canon Medical Systems Corporation, Hyperfine, Neural Analytics, Inc., and others.
Recent Developmental Activities in the Intracranial Pressure Monitoring Devices Market:
Key takeaways from the Intracranial Pressure Monitoring Devices market report study
Target audience who can be benefited from this Intracranial Pressure Monitoring Devices market report study
Frequently Asked Questions for the Intracranial Pressure Monitoring Devices Market:
Among all the regions, North America is estimated to hold a significant revenue share in the intracranial pressure monitoring devices market. This can be attributed to several factors, including the growing burden of Parkinson's disease, the increasing prevalence of brain injuries caused by trauma, and ongoing product development activities by regulatory authorities supported by the presence of key players in the region that contribute to the growth of the intracranial pressure monitoring devices market in the North America region during the forecast period from 2024 to 2030.